Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLDOPA vs METHYLPREDNISOLONE HEMISUCCINATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

METHYLDOPA vs METHYLPREDNISOLONE HEMISUCCINATE: Safety Overview

Metric METHYLDOPA METHYLPREDNISOLONE HEMISUCCINATE
Total FAERS Reports 2,604 153
Deaths Reported 73 24
Death Rate 2.8% 15.7%
Hospitalizations 728 76
Average Patient Age 32.1 yrs 49.6 yrs
% Female Patients 77.1% 53.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Rising Pharma Holdings, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A